CureLab Raises $3M in Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Curelab Veterinary News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Curelab Veterinary. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Curelab Veterinary Today - Breaking & Trending Today
CureLab Veterinary Launches Equity Crowdfunding Campaign on Netcapital to Revolutionize Medicine for Dogs, Cats, and Horses
/PRNewswire/ -- CureLab Veterinary, an emerging animal health biotech company, has launched its crowdfunding campaign via Netcapital, a leading investment...
Source: prnewswire.com
CureLab Veterinary Launches Equity Crowdfunding Campaign on Wefunder to Revolutionize Medicine for Dogs, Cats, and Horses
BOSTON, Mass. (PRWEB) June 09, 2022 -- CureLab Veterinary, an emerging animal health biotech company, has launched its equity crowdfunding campaign in
Source: prweb.com
University of Camerino Signs Strategic Partnership with CureLab Veterinary to Revolutionize Cancer Treatment for Companion Animals
BOSTON, USA and CAMERINO, ITALY (PRWEB) April 19, 2022 -- The University of Camerino (UniCam) has extended its strategic business partnership with CureLab
Source: prweb.com
CureLab Oncology Launches Veterinary Oncology Subsidiary, CureLab Veterinary
CureLab Oncology Launches Veterinary Oncology Subsidiary, CureLab Veterinary Based on a scientifically solid proof of concept in dogs and cats, an international IP portfolio, and a comprehensive scientific advisory board that includes key opinion leaders and experienced management, CureLab Veterinary intends to raise initial financing through a crowdfunding campaign set to launch within a month, and to become profitable within 36 months of raising funds. News provided by Share this article Share this article BOSTON, Jan. 21, 2021 /PRNewswire/ -- CureLab Oncology, a clinical-stage pre-IPO biot...
Source: prnewswire.com